Ependymoma Completed Phase 2 Trials for Memantine (DB01043)

Also known as: Brain Ependymoma / Ependymoma of Brain / Ependymomas / Ependymoma (morphologic abnormality) / Ependymoma (disorder) / Ependymoma of brain (disorder)

IndicationStatusPhase
DBCOND0017183 (Ependymoma)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03194906Memantine for Prevention of Cognitive Late Effects in Pediatric Patients Receiving Cranial Radiation Therapy for Localized Brain TumorsSupportive Care